Curated News
By: NewsRamp Editorial Staff
September 17, 2026
AHA: Women's Kidney Health Overlooked, Delaying Critical Care
TLDR
- American Heart Association statement reveals women face delayed CKD diagnosis and 30% fewer transplants, creating opportunities to lead in sex-specific kidney care.
- The statement explains how creatinine estimates, hormonal factors, pregnancy, and menopause affect women's kidney function, requiring sex-specific analyses in trials.
- The American Heart Association's statement aims to improve women's kidney health by embedding reproductive assessments in CKD care, reducing disparities and saving lives.
- Women's kidney health is often overlooked because common tests and research do not reflect female biology, according to a new American Heart Association statement.
Impact - Why it Matters
This news matters because it underscores a pervasive but often invisible health disparity: women are disproportionately affected by chronic kidney disease yet face systemic barriers to timely diagnosis and life-saving treatments. The American Heart Association’s statement not only sheds light on the biological and social factors driving these inequities but also provides a roadmap for change. By integrating reproductive health into kidney care and demanding sex-specific research, the medical community can move toward more personalized, effective interventions. For the public, this means greater awareness of kidney health as a women’s health issue and a push for advocacy to ensure equal access to care. Ultimately, closing these gaps could prevent countless cases of kidney failure, heart disease, and stroke, transforming outcomes for women globally.
Summary
The American Heart Association has issued a new scientific statement, “Women’s Kidney Health in Focus,” published in its flagship journal Circulation, highlighting critical gaps in the diagnosis and treatment of chronic kidney disease (CKD) among women. According to the statement, CKD affects about 1 in 10 women worldwide, yet women are less likely to receive timely diagnoses, begin dialysis, or undergo kidney transplants compared to men. The writing group, chaired by Eman Y. Gohar, Ph.D., M.S., FAHA, of Vanderbilt University Medical Center, points to a complex mix of biological and social factors—including genetics, hormones, menstrual health, pregnancy, postpartum changes, and menopause, as well as socioeconomic barriers like financial constraints and cultural expectations—that uniquely shape women’s kidney and cardiovascular health across their lifespan.
The statement outlines seven specific challenges women face in kidney care: underrepresentation in clinical trials, less access to treatment, delayed referrals, adverse pregnancy outcomes, menopause-related risks, more adverse effects from kidney medications, and lower rates of kidney transplant. It emphasizes that common kidney function tests, which rely on creatinine levels, may misclassify or delay CKD recognition in women due to differences in muscle mass. Additionally, conditions such as polycystic ovary syndrome and lupus are linked to higher CKD risk. To advance precision kidney medicine, the statement recommends embedding reproductive health assessments into routine CKD care, increasing women’s enrollment in clinical trials, conducting sex-specific analyses of study findings, and further investigating how female biology and life stages influence kidney function and treatment responses.
Ultimately, the American Heart Association calls for a multifaceted approach to close these gaps, noting that CKD is a major contributor to heart disease and stroke risk as part of cardiovascular-kidney-metabolic (CKM) syndrome. By tailoring care to women’s unique needs and ensuring their representation in research, the statement aims to drive earlier detection, safer treatments, and improved outcomes for millions of women worldwide.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, AHA: Women's Kidney Health Overlooked, Delaying Critical Care
